Journal of the American Academy of Dermatology
-
J. Am. Acad. Dermatol. · Mar 2019
A nomogram to identify high-risk melanoma patients with a negative sentinel lymph node biopsy.
Melanoma patients with negative nodes after sentinel lymph node biopsy are a heterogeneous group. Current guidelines fail to adequately stratify surveillance and treatment for this group. Also, there is scarce data on adjuvant treatments for these patients. ⋯ We created a predictive nomogram for melanoma patients with negative SLNBs. This nomogram is easy to use and identifies high-risk patients who should have more strict surveillance and be considered for adjuvant treatment.